Clinical trials
Completed Retinoblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 4 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 48 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 7 |
| St. Jude Children's Research Hospital | 6 |
| Children's Oncology Group | 4 |
| National Cancer Institute (NCI) | 4 |
| Sun Yat-sen University | 4 |
| Amsterdam UMC, location VUmc | 2 |
| Emory University | 2 |
| Washington University School of Medicine | 2 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Centre Hospitalier Universitaire de Liege | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinoblastoma | 48 |
| Neuroblastoma | 16 |
| Sarcoma | 13 |
| Medulloblastoma | 12 |
| Osteosarcoma | 12 |
| Wilms Tumor | 11 |
| Central Nervous System Neoplasms | 9 |
| Astrocytoma | 8 |
| Rhabdomyosarcoma | 8 |
| Optic Nerve Glioma | 7 |
Trials
Showing 51 to 48 of 48. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.